News
-
-
-
-
PRESS RELEASE
Pentixapharm Announces Expansion of Supervisory Board with the Appointment of Distinguished Endocrinologist Marcus Quinkler
Pentixapharm AG appoints distinguished endocrinologist Marcus Quinkler to its Supervisory Board. Quinkler's expertise in primary aldosteronism aligns with the company's focus on innovative radiopharmaceuticals
![Accesswire](/assets/images/accesswire-inline.png)
-
Tax990 Celebrates Record 990 Season: Clients Praise E-Filing Features And Exceptional Support
-
TealBook Launches Teal iQ, a Comprehensive Supplier Data Analysis and Enrichment Solution
-
Original Creations of Vera Neumann to Be Showcased at The Hamptons Fine Art Fair in NY
-
Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs)
-
Jeff Stanley Appointed Chief Commercial Officer at Fecon, LLC
![Les Echos](/assets/images/les-echos.png)
-
AXA: Information relating to the number of voting rights and shares making up the share capital on 30/06/2024
-
CDA - Loïc Bonhoure, Deputy CEO, steps down from his position
-
Disclosure of trading in own shares from July 1st, 2024, to July 5th, 2024. Detailed information per transaction
-
Reporting on share buyback transactions carried out on July 2, 2024
-
Disclosure of trading in own shares from July 1st, 2024, to July 5th, 2024